Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy
Keywords: مسیر سوربیتول; T2DM; type 2 diabetes mellitus; DN; diabetic nephropathy; ESRD; end stage renal disease; PLs; phospholipids; PG; phosphatidylglycerol; PE; phosphatidylethanolamine; PI; phosphatidylinositol; PS; phosphatidylserine; PC; phosphatidylcholine; SM; sphingomyel